A word from the manager: Gamma Capital Markets

‘Bayer could outperform the portfolio’

‘Pharmaceuticals and essential goods offer opportunities in the short term, but in the long term we prefer technology’

Carlo De Luca, Responsabile investimenti Gamma Capital Markets

4' min read

Translated by AI
Versione italiana

4' min read

Translated by AI
Versione italiana

Inflation and uncertainty over interest rates are prompting a review of portfolio decisions. The market is focusing on companies’ ability to generate returns on capital, as well as on earnings growth. According to Carlo De Luca, head of investments at Gamma Capital Markets, this rotation may favour value stocks and Europe, whilst keeping the US at the centre of the allocation. In the short to medium term, the preference is for defensive sectors, with Bayer and Coca-Cola among the favoured picks. Long-term confidence in the technology sector remains, accompanied by a more selective approach.

Inflation is rising again, adding uncertainty to the path of interest rates. How much of an impact does this have on the stock market outlook?

At present, oil is clearly the most dangerous component of inflation and is pulling back from its highs in the hope that there will be no geopolitical escalation. Setting that aside, and given that we must contend with rising logistics costs due to the Strait of Hormuz remaining impassable, we believe that expectations of a more restrictive monetary policy will have a negative impact on both the equity and fixed-income components of the portfolio over the next 12 months.

Loading...

What will change following the US mid-term elections? Which sectors stand to benefit?

The most obvious development is that renewable energy sources (above all, solar, hydrogen and uranium) have now been added to the shift already underway towards defensive assets such as pharmaceuticals and essential goods.Another sector that could benefit is banking, as the stimulus policies Trump would have implemented would have had a negative impact on both clients’ investment portfolios and those of the banks themselves (a factor that now significantly offsets even the increase in net interest income resulting from the rise in interest rates). As for technology companies, a distinction must be made between those that could continue to perform well (the hyperscalers that have already built their data centres) and those that, by supplying the equipment for the construction of data centres, now face the risk of being denied authorisation to build new ones.

Amid geopolitical tensions and rising costs, which businesses can protect their profit margins?

At this moment, rather than analysing how companies ensure growing margins, let us try not to lose sight of the paradigm shift that has already been evident for a few months: the market no longer looks solely at profit growth, but also at how capital is invested and how many years it takes for the investment to pay for itself. Consequently, we are focusing more on the ‘value’ aspect of companies than on their growth. We regard this as a bold shift in strategy that could also prove beneficial for the technology sector. After all, a rotation towards sectors that have lagged behind would help avoid a significant correction in share prices, which have now been characterised by two years of performance heavily concentrated in just a few stocks.

In the field of artificial intelligence, what sets apart the companies that are able to turn investments into profits?

It depends on the company’s financial strength. Those who spend less and burn through less cash, have already built their data centres, are less indebted and can sell new services to existing customers are in a privileged position.

Between the United States, Europe and emerging markets, where do you see the most opportunities?

Although earnings growth remains the preserve of the United States, if value were to outperform growth, Europe could benefit from the rotation and outperform both Wall Street and the emerging markets. We have increased our exposure to Europe partly because we expect the dollar to weaken slightly. However, the US market remains the dominant focus. We have diversified by investing in China, which could benefit from significant monetary stimulus and has already fallen by 25 per cent since the start of the year, and in gold, which is also being supported by central bank purchases.

Could the dominance of the banking and energy sectors, coupled with a shortage of technology, benefit the Milan Stock Exchange as inflation rises?

The Italian market lacks an index that reflects the country’s real economy and is hampered by the scarcity of listed sectors. Inflation alone cannot be the real driving force behind the Milan Stock Exchange. It could become so indirectly, if inflation and a monetary policy that does not meet expectations were to affect the performance of other international stock markets.

Still on the subject of Italia, do you prefer large companies or small and medium-sized enterprises?

We favour large banks and non-discretionary consumption. In recent major financial crises, the most significant corrections have mainly been driven by sell-offs in SME shares, which have proved to be more vulnerable.

Which shares do you consider to be the most interesting in the current market climate?

In the long term, we continue to favour technology stocks, although the sector is struggling in terms of investment. In the medium term, we are focusing on renewables, carefully selecting individual stocks; in the medium to short term, we prefer consumer staples and pharmaceuticals. Coca-Cola is representative of consumer staples: a value stock in developed markets and a growth stock in emerging markets. Bayer is a defensive stock and, should the correction in technology stocks continue, it could outperform the portfolio, having improved its forward EBITDA forecasts. First Solar is among the hardest-hit stocks in the renewables sector; Cameco mines, produces and markets uranium; Bloom Energy is one of the sector’s leading players and has increased its revenue in 2026. Nvidia sells the entire artificial intelligence infrastructure. AMD manufactures CPUs – distinct from Nvidia’s GPUs – with excellent prospects. Meta has artificial intelligence agents and the channels to monetise them via social media; Microsoft offers agents to businesses. Novartis is one of the sector’s most highly capitalised companies and has very strong projected earnings growth.

Copyright reserved ©
Loading...

Brand connect

Loading...

Newsletter

Notizie e approfondimenti sugli avvenimenti politici, economici e finanziari.

Iscriviti